Dopaminergic stabilizer pridopidine shows promise for Huntington's disease patients

被引：0
|
作者：
McGuinness, Laura
机构：
来源：
EXPERT REVIEW OF CLINICAL PHARMACOLOGY | 2012年 / 5卷 / 01期
关键词：
D O I：
10.1586/ECP.11.74
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of the dopaminergic stabilizer pridopidine (ACR16) in patients with Huntington's disease
    Lundin, A.
    Dietrichs, E.
    Haghighi, S.
    Goeller, M.-L.
    Heiberg, A.
    Loutfi, G.
    Widner, H.
    Wiktorin, K.
    Wiklund, L.
    Svenningsson, A.
    Sonesson, C.
    Waters, N.
    Waters, S.
    Tedroff, J.
    [J]. MOVEMENT DISORDERS, 2010, 25 (07) : S274 - S274
  • [2] Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease
    Lundin, Anders
    Dietrichs, Espen
    Haghighi, Sara
    Goller, Marine-Louise
    Heiberg, Arvid
    Loutfi, Ghada
    Widner, Hakan
    Wiktorin, Klas
    Wiklund, Leif
    Svenningsson, Anders
    Sonesson, Clas
    Waters, Nicholas
    Waters, Susanna
    Tedroff, Joakim
    [J]. CLINICAL NEUROPHARMACOLOGY, 2010, 33 (05) : 260 - 264
  • [3] Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease (vol 33, pg 260, 2010)
    Lundin, A.
    Dietrichs, E.
    Haghighi, S.
    [J]. CLINICAL NEUROPHARMACOLOGY, 2011, 34 (05) : 200 - 200
  • [4] In vivo pharmacology of the dopaminergic stabilizer pridopidine
    Ponten, Henrik
    Kullingsjo, Johan
    Lagerkvist, Soren
    Martin, Peter
    Pettersson, Fredrik
    Sonesson, Clas
    Waters, Susanna
    Waters, Nicholas
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 644 (1-3) : 88 - 95
  • [5] Research shows promise for Huntington's disease treatment
    不详
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (03) : 332 - 332
  • [6] Pridopidine for the treatment of Huntington's disease
    Shannon, Kathleen M.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (04) : 485 - 492
  • [7] Pridopidine in the treatment of Huntington's disease
    Jablonska, Magdalena
    Grzelakowska, Klaudyna
    Wisniewski, Bartlomiej
    Mazur, Ewelina
    Leis, Kamil
    Galazka, Przemyslaw
    [J]. REVIEWS IN THE NEUROSCIENCES, 2020, 31 (04) : 441 - 451
  • [8] The Pridopidine Paradox in Huntington's Disease
    Reilmann, Ralf
    [J]. MOVEMENT DISORDERS, 2013, 28 (10) : 1321 - 1324
  • [9] The effect of renal impairment on the pharmacokinetics of pridopidine, a new dopamine stabilizer for treatment of Huntington's disease
    Rabinovich-Guilatt, L.
    Siegler, K. E.
    Schultz, A.
    Halabi, A.
    Rembratt, A.
    Wickenberg, A.
    Spiegelstein, O.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S213 - S214
  • [10] NeuroSearch's dopaminergic stabilizer improves movement disorders in Huntington's disease
    [J]. Nature Reviews Drug Discovery, 2010, 9 : 260 - 260
12345